Dec 4 2025 - Heron Therapeutics Announces Inclusion of APONVIE® (aprepitant) Injectable...
Nov 4 2025 - Heron Therapeutics Announces Q3 2025 Financial Results and Highlights Commercial...
Oct 29 2025 - Heron Therapeutics Announces Appointment of Thomas Cusack to Board of Directors...
Oct 21 2025 - Heron Therapeutics to Report Third Quarter 2025 Financial Results on Tuesday,...
Thank you for submitting your request. A Heron Therapeutics representative will be in contact.
Instructions: This form is intended for use by trained CrossLink representatives regarding questions from US Medical Professionals only. Fields marked with an asterisk (*) are mandatory.
Unsolicited Medical Information Request for ZYNRELEF® (bupivacaine and meloxicam) extended-release solution
A signature will not be collected on this form.